Zdeněk Adam
- Hematology top 2%
- Molecular Biology
- Oncology top 10%
- Cancer Research
- Physiology
- Co-authors
- Roman HájekMarta KrejčíJiří VorlíčekLuděk PourTomáš BüchlerPetr KuglíkHeinz GisslingerRichard Greil
- Topics
- Multiple Myeloma Research and Treatments (54 papers)Histiocytic Disorders and Treatments (32 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (23 papers)
- Cited by
- HematologyOncologyGenetics
In The Last Decade
Zdeněk Adam
122 papers receiving 894 citations
Peers
Comparison fields: 5 of 65
- Hematology 522
- Molecular Biology 482
- Oncology 298
- Cancer Research 134
- Physiology 131
Countries citing papers authored by Zdeněk Adam
This map shows the geographic impact of Zdeněk Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zdeněk Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zdeněk Adam more than expected).
Fields of papers citing papers by Zdeněk Adam
This network shows the impact of papers produced by Zdeněk Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zdeněk Adam. The network helps show where Zdeněk Adam may publish in the future.
Co-authorship network of co-authors of Zdeněk Adam
This figure shows the co-authorship network connecting the top 25 collaborators of Zdeněk Adam. A scholar is included among the top collaborators of Zdeněk Adam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zdeněk Adam. Zdeněk Adam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 2 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 0 | |
| 7 | [The patient complains of spinal pain or fatigue and weakness. How do I recognize whether their cause is spondylarthrosis, the patients age or multiple myeloma?]. | 1 |
| 8 | Diagnostika a léčba Waldenströmovy makroglobulinemie | 0 |
| 9 | 93 | |
| 10 | 1 | |
| 11 | 22 | |
| 12 | 10 | |
| 13 | Choroby způsobené ukládáním monoklonálních imunoglobulinů | 0 |
| 14 | 34 | |
| 15 | Evaluation of HGF and Endostatin in the bone marrow of patients with multiple myeloma and the effect of peripheral blood admixture | 1 |
| 16 | Mnohočetný myelom - časná diagnostika | 0 |
| 17 | Histiocytóza z Langerhansových buněk u dospělých osob | 0 |
| 18 | Exathema and herpes zoster infection during Velcade use incidence, treatment and profylaxis | 1 |
| 19 | 9 | |
| 20 | Vinorelbine and cisplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter Czech study. | 6 |
About Zdeněk Adam
Zdeněk Adam is a scholar working on Hematology, Genetics and Oncology, having authored 156 papers that have together received 929 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (54 papers), Histiocytic Disorders and Treatments (32 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (23 papers). The work is most often cited by research in Hematology (522 citations), Oncology (298 citations) and Genetics (100 citations). Zdeněk Adam has collaborated with scholars based in Czechia, Austria and Germany. Frequent co-authors include Roman Hájek, Marta Krejčí, Jiří Vorlíček, Luděk Pour, Tomáš Büchler, Luděk Pour, Petr Kuglík, Heinz Gisslinger, Luděk Pour and Richard Greil. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.